Skip to main content

ORIGINAL RESEARCH article

Front. Epidemiol.
Sec. Infectious Disease Epidemiology
Volume 4 - 2024 | doi: 10.3389/fepid.2024.1436506

Prevalence and Factors Influencing Low-Level Viremia in People Living with HIV/AIDS in Guizhou Province, China

Provisionally accepted
Yan Zheng Yan Zheng 1Xinling Zha Xinling Zha 2Hai Long Hai Long 1Wenji Zeng Wenji Zeng 1Junhua Wang Junhua Wang 2Yongming Yao Yongming Yao 3Lu Huang Lu Huang 3Xiaotian Song Xiaotian Song 3Maosi Wang Maosi Wang 3Yang Chen Yang Chen 3*
  • 1 Guiyang Public Health Jiuzhi Center, Guiyang, Guizhou Province, China
  • 2 School of Public Health,the key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education,Guizhou Medical University,Guiyang 561113,China, Guiyang, Guizhou Province, China
  • 3 Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China

The final, formatted version of the article will be published soon.

    The frequency of low-level viremia (LLV) may differ within China. Therefore, this study aimed to analyze the epidemiological characteristics and factors influencing LLV among people living with HIV/AIDS in Guizhou Province from 2016 to 2022.In this retrospective cohort study, we analyzed people living with HIV/AIDS whose demographic data, CD4 + T lymphocyte count, and viral load. We divided the people living with HIV/AIDS into two sub-cohorts based on whether they experienced LLV.We compared the occurrence of LLV at different levels and frequencies, as well as the risk of virological failure (VF), using the Chi-square test. We also assessed the risk of death.Non-conditional binary logistic regression analysis was used to identify factors influencing LLV.In total, 28,613 cases of infection were analyzed, with 33.72% (9,649/28,613) exhibiting LLV. The LLV rates were 20.69%, 6.50%, and 6.48% in the low-level LLV (LLLV) (50-199 copies/mL), medium-level LLV (MLLV) (200-399 copies/mL), and high-level LLV (HLLV) (400-999 copies/mL) groups, respectively. The intermittent LLV (iLLV) and persistent LLV (pLLV) groups had LLV rates of 28.65% and 5.07%, respectively. The VF rates were 6.18%, 11.79%, and 13.70% in the LLLV, MLLV, and HLLV groups, respectively (P<0.001). The iLLV and pLLV groups had VF rates of 8.82% and 8.14%, respectively (P=0.397). Mortality was 7.83% in the LLV group and 7.04% in the non-LLV group, which was higher in the LLV group than in the non-LLV group (P=0.030). Multivariate logistic regression analysis revealed that the baseline World Health Organization clinical stage, age at antiretroviral therapy initiation, gender, marital status, ethnicity, baseline CD4 + T lymphocyte count, and initial treatment regimen were factors influencing the occurrence of LLV.The incidence of LLV in people living with HIV/AIDS in Guizhou Province was relatively high. Comprehensive consideration of various influencing factors should be undertaken to improve the antiretroviral treatment effect, adherence education, and quality of life.

    Keywords: AIDS, Antiretroviral therapy, Epidemiological characteristics, Guizhou Province, Influencing factors, Low-level viremia human immunodeficiency virus AIDS, antiretroviral therapy, Epidemiological characteristics, Guizhou Province, Influencing factors, Low-level viremia human immunodeficiency virus

    Received: 22 May 2024; Accepted: 23 Sep 2024.

    Copyright: © 2024 Zheng, Zha, Long, Zeng, Wang, Yao, Huang, Song, Wang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Yang Chen, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.